{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T04:55:39Z","timestamp":1787374539942,"version":"build-2736575974"},"reference-count":26,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,3]],"date-time":"2024-05-03T00:00:00Z","timestamp":1714694400000},"content-version":"vor","delay-in-days":2,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Immunobiology"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.imbio.2024.152808","type":"journal-article","created":{"date-parts":[[2024,5,9]],"date-time":"2024-05-09T01:52:14Z","timestamp":1715219534000},"page":"152808","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["The safety and efficacy of tumor necrosis factor-alpha inhibitor on pregnancy outcomes in patients with unexplained recurrent miscarriage"],"prefix":"10.1016","volume":"229","author":[{"given":"Fangxiang","family":"Mu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianghui","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.imbio.2024.152808_b0005","doi-asserted-by":"crossref","first-page":"1201439","DOI":"10.3389\/fimmu.2024.1201439","article-title":"IL-6 signaling drives self-renewal and alternative activation of adipose tissue macrophages","volume":"15","author":"Ackermann","year":"2024","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.imbio.2024.152808_b0010","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1007\/s12016-016-8596-x","article-title":"Tumor Necrosis Factor-Alpha and Pregnancy: Focus on Biologics. An Updated and Comprehensive Review","volume":"53","author":"Alijotas-Reig","year":"2017","journal-title":"Clinical Reviews in Allergy & Immunology."},{"issue":"2","key":"10.1016\/j.imbio.2024.152808_b0015","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1210\/jc.2003-031351","article-title":"Tumor necrosis factor-alpha inhibits trophoblast migration through elevation of plasminogen activator inhibitor-1 in first-trimester villous explant cultures","volume":"89","author":"Bauer","year":"2004","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"10.1016\/j.imbio.2024.152808_b0020","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s12916-022-02697-3","article-title":"Thyroid dysfunction in Chinese nasopharyngeal carcinoma after anti-PD-1 therapy and its association with treatment response","volume":"21","author":"Chen","year":"2023","journal-title":"BMC Med."},{"issue":"3","key":"10.1016\/j.imbio.2024.152808_b0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.fertnstert.2015.11.027","article-title":"Oocyte vitrification as an efficient option for elective fertility preservation","volume":"105","author":"Cobo","year":"2016","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.imbio.2024.152808_b0030","doi-asserted-by":"crossref","first-page":"e26","DOI":"10.1017\/erm.2022.18","article-title":"TNF-\u03b1\/anti-TNF-\u03b1 drugs and its effect on pregnancy outcomes","volume":"24","author":"Dai","year":"2022","journal-title":"Expert Rev. Mol. Med."},{"issue":"5","key":"10.1016\/j.imbio.2024.152808_b0035","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.tjog.2019.07.007","article-title":"A randomized controlled trial of etanercept in the treatment of refractory recurrent spontaneous abortion with innate immune disorders","volume":"58","author":"Fu","year":"2019","journal-title":"Taiwan. J. Obstet. Gynecol."},{"issue":"6","key":"10.1016\/j.imbio.2024.152808_b0040","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1080\/01443615.2019.1576600","article-title":"A review of reproductive outcomes of women with two consecutive miscarriages and no living child","volume":"39","author":"Green","year":"2019","journal-title":"J. Obstetrics Gynaecol."},{"issue":"2","key":"10.1016\/j.imbio.2024.152808_b0045","doi-asserted-by":"crossref","first-page":"71","DOI":"10.2165\/11318100-000000000-00000","article-title":"Effect of obesity on the pharmacokinetics of drugs in humans","volume":"49","author":"Hanley","year":"2010","journal-title":"Clin. Pharmacokinet."},{"issue":"12","key":"10.1016\/j.imbio.2024.152808_b0050","doi-asserted-by":"crossref","first-page":"2320","DOI":"10.1111\/jcpt.13771","article-title":"Tumour necrosis factor inhibitor combined with intravenous immunoglobulin and heparin for treatment of recurrent spontaneous abortion: A two-centre, retrospective, cohort study","volume":"47","author":"Jiang","year":"2022","journal-title":"J. Clin. Pharm. Ther."},{"issue":"5","key":"10.1016\/j.imbio.2024.152808_b0055","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1093\/humupd\/8.5.463","article-title":"Recurrent miscarriage: aetiology, management and prognosis","volume":"8","author":"Li","year":"2002","journal-title":"Hum. Reprod. Update"},{"issue":"1","key":"10.1016\/j.imbio.2024.152808_b0060","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/s12958-017-0315-9","article-title":"Low-dose lymphocyte immunotherapy rebalances the peripheral blood Th1\/Th2\/Treg paradigm in patients with unexplained recurrent miscarriage","volume":"15","author":"Liu","year":"2017","journal-title":"Reproductive Biology and Endocrinology: RB&E"},{"issue":"10","key":"10.1016\/j.imbio.2024.152808_b0065","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1111\/jog.14083","article-title":"Risk Factors and Outcomes of Recurrent Pregnancy Loss in Japan","volume":"45","author":"Morita","year":"2019","journal-title":"J. Obstet. Gynaecol. Res."},{"issue":"9","key":"10.1016\/j.imbio.2024.152808_b0070","doi-asserted-by":"crossref","first-page":"e064780","DOI":"10.1136\/bmjopen-2022-064780","article-title":"Intravenous immunoglobulin and prednisolone to women with unexplained recurrent pregnancy loss after assisted reproductive technology treatment: a protocol for a randomised, double-blind, placebo-controlled trial","volume":"12","author":"N\u00f8rgaard-Pedersen","year":"2022","journal-title":"BMJ Open"},{"issue":"4","key":"10.1016\/j.imbio.2024.152808_b0075","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1007\/s10815-019-01415-y","article-title":"Maternal age, history of miscarriage, and embryonic\/fetal size are associated with cytogenetic results of spontaneous early miscarriages","volume":"36","author":"Ozawa","year":"2019","journal-title":"J. Assist. Reprod. Genet."},{"issue":"10285","key":"10.1016\/j.imbio.2024.152808_b0080","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1016\/S0140-6736(21)00682-6","article-title":"Miscarriage matters: the epidemiological, physical, psychological, and economic costs of early pregnancy loss","volume":"397","author":"Quenby","year":"2021","journal-title":"Lancet (london, England)."},{"issue":"8","key":"10.1016\/j.imbio.2024.152808_b0085","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1111\/aogs.13352","article-title":"Treatment efficacy for idiopathic recurrent pregnancy loss - a systematic review and meta-analyses","volume":"97","author":"Rasmark Roepke","year":"2018","journal-title":"Acta Obstet. Gynecol. Scand."},{"issue":"1","key":"10.1016\/j.imbio.2024.152808_b0090","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s12906-023-04226-y","article-title":"A crossover randomized controlled trial examining the effects of black seed (Nigella sativa) supplementation on IL-1\u03b2, IL-6 and leptin, and insulin parameters in overweight and obese women","volume":"24","author":"Razmpoosh","year":"2024","journal-title":"BMC Complementary Medicine and Therapies"},{"issue":"6","key":"10.1016\/j.imbio.2024.152808_b0095","doi-asserted-by":"crossref","first-page":"2922","DOI":"10.3390\/ijms22062922","article-title":"The Role of TNF-\u03b1 and Anti-TNF-\u03b1 Agents during Preconception","volume":"22","author":"Romanowska-Pr\u00f3chnicka","year":"2021","journal-title":"Pregnancy, and Breastfeeding. International Journal of Molecular Sciences."},{"key":"10.1016\/j.imbio.2024.152808_b0100","doi-asserted-by":"crossref","unstructured":"RPL EGGo, Bender Atik R, Christiansen OB, Elson J, Kolte AM, Lewis S, et al. ESHRE guideline: recurrent pregnancy loss: an update in 2022. Hum Reprod Open. 2023;2023(1):hoad002.","DOI":"10.1093\/hropen\/hoad002"},{"issue":"10","key":"10.1016\/j.imbio.2024.152808_b0105","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1080\/09513590.2020.1727433","article-title":"Assessment of endometrial receptivity during implantation window in women with unexplained infertility","volume":"36","author":"Wang","year":"2020","journal-title":"Gynecological Endocrinology: the Official Journal of the International Society of Gynecological Endocrinology."},{"key":"10.1016\/j.imbio.2024.152808_b0110","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.3389\/fimmu.2020.02025","article-title":"T Helper (Th) Cell Profiles in Pregnancy and Recurrent Pregnancy Losses: Th1\/Th2\/Th9\/Th17\/Th22\/Tfh Cells","volume":"11","author":"Wang","year":"2020","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.imbio.2024.152808_b0115","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.1600-0897.2008.00585.x","article-title":"Treatment with tumor necrosis factor inhibitors and intravenous immunoglobulin improves live birth rates in women with recurrent spontaneous abortion","volume":"60","author":"Winger","year":"2008","journal-title":"Am. J. Reprod. Immunol."},{"issue":"6","key":"10.1016\/j.imbio.2024.152808_b0120","doi-asserted-by":"crossref","first-page":"847","DOI":"10.3892\/mmr.2021.12487","article-title":"Tumor necrosis factor inhibitors as therapeutic agents for recurrent spontaneous abortion (Review)","volume":"24","author":"Wu","year":"2021","journal-title":"Mol. Med. Rep."},{"issue":"2","key":"10.1016\/j.imbio.2024.152808_b0125","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1111\/aji.12447","article-title":"Association between Serum TNF-\u03b1 Levels and Recurrent Spontaneous Miscarriage: A Meta-analysis","volume":"75","author":"Zhang","year":"2016","journal-title":"Am. J. Reprod. Immunol."},{"issue":"1","key":"10.1016\/j.imbio.2024.152808_b0130","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s12865-019-0290-3","article-title":"Patients with idiopathic recurrent miscarriage have abnormally high TGF\u00df+ blood NK, NKT and T cells in the presence of abnormally low TGF\u00df plasma levels","volume":"20","author":"Zhu","year":"2019","journal-title":"BMC Immunol."}],"container-title":["Immunobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0171298524000263?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0171298524000263?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T22:12:24Z","timestamp":1717279944000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0171298524000263"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":26,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["S0171298524000263"],"URL":"https:\/\/doi.org\/10.1016\/j.imbio.2024.152808","relation":{},"ISSN":["0171-2985"],"issn-type":[{"value":"0171-2985","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The safety and efficacy of tumor necrosis factor-alpha inhibitor on pregnancy outcomes in patients with unexplained recurrent miscarriage","name":"articletitle","label":"Article Title"},{"value":"Immunobiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.imbio.2024.152808","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier GmbH.","name":"copyright","label":"Copyright"}],"article-number":"152808"}}